ArticleBlood research2021

Outcomes of bortezomib combination chemotherapies in autologous stem cell transplantation-ineligible patients with AL amyloidosis.

Joon Young Hur et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.